CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

ADPS 1g  | ≥99%

CSNpharm

ADPS is a highly water-soluble aniline derivatives, are widely used in diagnostic tests and biochemical tests.

More Information Supplier Page

ADPS 100mg  | ≥99%

CSNpharm

ADPS is a highly water-soluble aniline derivatives, are widely used in diagnostic tests and biochemical tests.

More Information Supplier Page

AEBSF HCl 100mg  | ≥99%

CSNpharm

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

More Information Supplier Page

AEBSF HCl 250mg  | ≥99%

CSNpharm

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

More Information Supplier Page

Afegostat 5mg  | ≥98%

CSNpharm

Afegostat was previously in phase II clinical trials for the treatment of Gaucher’s disease. The experiment was discontinued.

More Information Supplier Page

Afegostat 25mg  | ≥98%

CSNpharm

Afegostat was previously in phase II clinical trials for the treatment of Gaucher’s disease. The experiment was discontinued.

More Information Supplier Page

Afegostat 1mg  | ≥98%

CSNpharm

Afegostat was previously in phase II clinical trials for the treatment of Gaucher’s disease. The experiment was discontinued.

More Information Supplier Page

Afegostat 10mg  | ≥98%

CSNpharm

Afegostat was previously in phase II clinical trials for the treatment of Gaucher’s disease. The experiment was discontinued.

More Information Supplier Page

Afegostat 50mg  | ≥98%

CSNpharm

Afegostat was previously in phase II clinical trials for the treatment of Gaucher’s disease. The experiment was discontinued.

More Information Supplier Page

Afobazole HCl 25mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

Afobazole HCl 100mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

Afobazole HCl 1mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

Afobazole HCl 50mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

Afobazole HCl 5mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

Afobazole HCl 10mg  | ≥99%

CSNpharm

Afobazole HCl is an anxiolytic drug and produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.

More Information Supplier Page

AG 045572 1mg  | ≥98%

CSNpharm

AG 045572 is a selective antagonist of gonadotropin-releasing hormone (GnRH) receptor with Ki value of 6.0 nM.

More Information Supplier Page

AG 556 10mg  | ≥98%

CSNpharm

AG 556 is an EGFR kinase inhibitor with IC50 value of 1.1μM, selective over ErbB2 (IC50 > 500 μM).

More Information Supplier Page

AG 556 50mg  | ≥98%

CSNpharm

AG 556 is an EGFR kinase inhibitor with IC50 value of 1.1μM, selective over ErbB2 (IC50 > 500 μM).

More Information Supplier Page

AG 99 5mg  | ≥98%

CSNpharm

AG 99 is an EGF receptor kinase inhibitor with IC50 of 10 µM in the human epidermoid carcinoma cell line A431.

More Information Supplier Page

AG 99 1mg  | ≥98%

CSNpharm

AG 99 is an EGF receptor kinase inhibitor with IC50 of 10 µM in the human epidermoid carcinoma cell line A431.

More Information Supplier Page

AG-490 250mg  | ≥99%

CSNpharm

AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.

More Information Supplier Page

AG-490 10mg  | ≥99%

CSNpharm

AG-490 is a broad-spectrum inhibitor that has several targets including EGFR (IC50 = 2 μM), ErbB2 (IC50 = 13.5 μM), STAT3 and JAK2.

More Information Supplier Page